Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,506.67
1,272.30
1,071.71
1,001.70
700.34
665.83
585.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,506.67
1,272.30
1,071.71
1,001.70
700.34
665.83
585.66
Raw Material Cost
521.15
507.42
461.08
452.89
269.16
268.45
227.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
185.74
167.09
134.23
172.08
175.23
161.10
128.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
39.57
57.41
64.85
35.89
28.78
40.07
46.85
Selling and Distribution Expenses
802.80
676.82
531.61
499.34
396.76
368.40
320.01
Other Expenses
-22.53
-22.45
-19.91
-20.80
-20.40
-20.12
-17.52
Total Expenditure (Excl Depreciation)
1,323.95
1,184.24
992.70
952.23
665.93
636.85
547.32
Operating Profit (PBDIT) excl Other Income
182.7
88.10000000000001
79
49.5
34.4
29
38.3
Other Income
3.82
1.83
1.78
0.68
0.17
-7.75
-6.07
Operating Profit (PBDIT)
272.92
163.60
157.28
128.54
105.16
94.05
94.80
Interest
39.57
57.41
64.85
35.89
28.78
40.07
46.85
Exceptional Items
0.00
0.00
0.01
0.00
0.01
-0.00
32.10
Gross Profit (PBDT)
985.52
764.89
610.62
548.81
431.18
397.38
358.35
Depreciation
86.38
73.70
76.49
78.51
70.58
72.83
62.53
Profit Before Tax
146.97
32.49
15.95
14.14
5.80
-18.85
17.52
Tax
30.79
7.86
28.67
-2.27
3.50
-13.10
29.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
116.18
24.63
-12.73
16.41
2.30
-5.75
-11.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
116.18
24.63
-12.73
16.41
2.30
-5.75
-11.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
116.18
24.63
-12.73
16.41
2.30
-5.75
-11.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
912.46
798.56
473.61
494.37
476.51
472.85
479.33
Earnings per share (EPS)
0.27
0.06
-0.03
0.04
0.01
-0.01
-0.03
Diluted Earnings per share
0.27
0.06
-0.03
0.04
0.01
-0.01
-0.03
Operating Profit Margin (Excl OI)
12.13%
6.92%
7.37%
4.93%
4.91%
4.35%
6.55%
Gross Profit Margin
15.49%
8.35%
8.63%
9.25%
10.91%
8.11%
13.67%
PAT Margin
7.71%
1.94%
-1.19%
1.64%
0.33%
-0.86%
-2.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 18.42% vs 18.72% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 372.36% vs 293.70% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 66.32% vs 4.05% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -31.01% vs -11.56% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Singhe Hospitals PLC With
Figures in Million
Consolidate Annual Results
Change(LKR)
Change(%)
Net Sales
1,506.67
13,650.11
-12,143.44
-88.96%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,506.67
13,650.11
-12,143.44
-88.96%
Raw Material Cost
521.15
8,015.19
-7,494.04
-93.50%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
185.74
3,449.68
-3,263.94
-94.62%
Power Cost
0
0
0.00
Manufacturing Expenses
39.57
57.94
-18.37
-31.71%
Selling and Distribution Expenses
802.80
2,757.81
-1,955.01
-70.89%
Other Expenses
-22.53
-350.76
328.23
93.58%
Total Expenditure (Excl Depreciation)
1,323.95
10,773.01
-9,449.06
-87.71%
Operating Profit (PBDIT) excl Other Income
182.72
2,877.10
-2,694.38
-93.65%
Other Income
3.82
-923.83
927.65
100.41%
Operating Profit (PBDIT)
272.92
2,716.68
-2,443.76
-89.95%
Interest
39.57
57.94
-18.37
-31.71%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
985.52
5,634.91
-4,649.39
-82.51%
Depreciation
86.38
763.42
-677.04
-88.69%
Profit Before Tax
146.97
1,895.32
-1,748.35
-92.25%
Tax
30.79
555.89
-525.10
-94.46%
Provisions and contingencies
0
0
0.00
Profit After Tax
116.18
1,339.43
-1,223.25
-91.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
116.18
1,339.43
-1,223.25
-91.33%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
116.18
1,339.43
-1,223.25
-91.33%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
912.46
14,178.40
-13,265.94
-93.56%
Earnings per share (EPS)
0.27
5.99
-5.72
-95.49%
Diluted Earnings per share
0.27
5.99
-5.72
-95.49%
Operating Profit Margin (Excl OI)
12.13%
21.08%
0.00
-8.95%
Gross Profit Margin
15.49%
19.48%
0.00
-3.99%
PAT Margin
7.71%
9.81%
0.00
-2.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 150.67 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 18.42% vs 18.72% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 11.62 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 372.36% vs 293.70% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.91 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 66.32% vs 4.05% in Mar 2024
Annual - Interest
Interest 3.96 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -31.01% vs -11.56% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.13%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






